MD2850G2 - Metodă de inducere a avortului medicamentos - Google Patents

Metodă de inducere a avortului medicamentos Download PDF

Info

Publication number
MD2850G2
MD2850G2 MDA20050046A MD20050046A MD2850G2 MD 2850 G2 MD2850 G2 MD 2850G2 MD A20050046 A MDA20050046 A MD A20050046A MD 20050046 A MD20050046 A MD 20050046A MD 2850 G2 MD2850 G2 MD 2850G2
Authority
MD
Moldova
Prior art keywords
medicamental
abortion
inducing
hours
administered
Prior art date
Application number
MDA20050046A
Other languages
English (en)
Russian (ru)
Other versions
MD2850F1 (ro
Inventor
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Людмила ФРИПТУ
Михаил ТОДИРАШ
Екатерина СТРАТУ
Корина КАРДАНЮК
Original Assignee
Валентин ФРИПТУ
Виктор ГИКАВЫЙ
Людмила ФРИПТУ
Михаил ТОДИРАШ
Екатерина СТРАТУ
Корина КАРДАНЮК
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Валентин ФРИПТУ, Виктор ГИКАВЫЙ, Людмила ФРИПТУ, Михаил ТОДИРАШ, Екатерина СТРАТУ, Корина КАРДАНЮК filed Critical Валентин ФРИПТУ
Priority to MDA20050046A priority Critical patent/MD2850G2/ro
Publication of MD2850F1 publication Critical patent/MD2850F1/ro
Publication of MD2850G2 publication Critical patent/MD2850G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special la obstetrică şi ginecologie şi poate fi utilizată pentru întreruperea sarcinii la termene mici şi anume până la 56 zile, asociate cu amenoree.Esenţa invenţiei constă în aceea că se administrează per os 200 mg de mifepriston, apoi, peste 24…48 de ore, se administrează de patru ori intravaginal peste fiecare 6 ore câte un supozitor, care conţine 50 mg de bromură de S-etilizotiouroniu (izoturon).
MDA20050046A 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos MD2850G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (ro) 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050046A MD2850G2 (ro) 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos

Publications (2)

Publication Number Publication Date
MD2850F1 MD2850F1 (ro) 2005-09-30
MD2850G2 true MD2850G2 (ro) 2006-07-31

Family

ID=35057541

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050046A MD2850G2 (ro) 2005-02-18 2005-02-18 Metodă de inducere a avortului medicamentos

Country Status (1)

Country Link
MD (1) MD2850G2 (ro)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD215Z (ro) * 2007-10-16 2010-12-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Dispozitiv de încărcare a acumulatorului capacitiv
MD20070283A (ro) * 2007-10-16 2009-07-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Procedeu de formare a curentului de încărcare pentru un acumulator de energie capacitiv
MD4073C1 (ro) * 2008-11-06 2011-05-31 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Convertizor stabilizat de tensiune înaltă
MD281Z (ro) * 2009-10-23 2011-04-30 Институт Электронной Инженерии И Промышленных Технологий Академии Наук Молдовы Convertor de tensiune cu rezonanţă reglabil

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263B1 (ro) * 1995-03-01 1995-08-31 Victor GHICAVII Remediu cu actiune antihipotensiva "izoturon"
MD1223B1 (ro) * 1997-07-15 1999-05-31 Univ Nicolae Testemitanu Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu in calitate de substanta vaso-con-strictoare si preparat farmaceutic pe baza lui
MD1431F1 (ro) * 1998-01-16 2000-03-31 Univ Nicolae Testemitanu Remedii antihipotensive
MD2228F1 (ro) * 2003-01-21 2003-08-31 Univ Nicolae Testemitanu Utilizarea derivatilor izotiouronici in tratamentul si profilaxia atoniei intestinale
MD2323F1 (ro) * 2003-06-23 2003-12-31 Univ Nicolae Testemitanu Utilizarea bromurii de S-etilizotiouroniu (izoturon) in calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine in cazul miomului uterin
MD2491F1 (ro) * 2004-02-10 2004-07-31 Victor GHICAVII Utilizarea bromurii de S-etilizotiouroniu (izoturonului) pentru tratamentul algodismenoreei

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD263B1 (ro) * 1995-03-01 1995-08-31 Victor GHICAVII Remediu cu actiune antihipotensiva "izoturon"
MD1223B1 (ro) * 1997-07-15 1999-05-31 Univ Nicolae Testemitanu Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu in calitate de substanta vaso-con-strictoare si preparat farmaceutic pe baza lui
MD1431F1 (ro) * 1998-01-16 2000-03-31 Univ Nicolae Testemitanu Remedii antihipotensive
MD2228F1 (ro) * 2003-01-21 2003-08-31 Univ Nicolae Testemitanu Utilizarea derivatilor izotiouronici in tratamentul si profilaxia atoniei intestinale
MD2323F1 (ro) * 2003-06-23 2003-12-31 Univ Nicolae Testemitanu Utilizarea bromurii de S-etilizotiouroniu (izoturon) in calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine in cazul miomului uterin
MD2491F1 (ro) * 2004-02-10 2004-07-31 Victor GHICAVII Utilizarea bromurii de S-etilizotiouroniu (izoturonului) pentru tratamentul algodismenoreei

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Schaff E., Fielding S., Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception. 2002 Oct; 66(4), p. 247-250 *

Also Published As

Publication number Publication date
MD2850F1 (ro) 2005-09-30

Similar Documents

Publication Publication Date Title
BR0007360A (pt) Composição de liberação controlada
EA201200377A1 (ru) Способ пероральной контрацепции у женщин, способ управления нежелательными кровотечениями и предназначенная для применения в этих способах фармацевтическая упаковка
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
BRPI0617683A2 (pt) processo para a contracepção hormonal preventiva segundo a necessidade e uso de um emplastro transdérmico
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
CN103263318A (zh) 一种睾丸冷敷贴及其制备方法
Rahayu et al. Effect of vitamin C on testosterone level, sperm count and sperm morphology in gentamicin-induced Wistar rats
PE20050665A1 (es) ESTROGENOS SELECTIVOS DE 8ß-VINIL-ESTRA-1,3,5(10)-TRIEN-3,17ß-DIOL Y 17ß-FLUOR-9-VINIL-ESTRA-1,3,6(10)-TRIEN-3,16ALFA-DIOL
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
Farajkhoda et al. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe
Park et al. Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction
HUP0203050A2 (hu) Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények
GB2407504A (en) Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
TW200501957A (en) Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin Ⅱ antagonist for stroke prevention
MD2850F1 (ro) Metoda de inducere a avortului medicamentos
BOARD Endometrial carbonic anhydrase after diethylstilbestrol as a postcoital antifertility agent
Check et al. Improved implantation and live delivered pregnancy rates following transfer of embryos derived from donor oocytes by single injection of leuprolide in mid-luteal phase
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol
Mishra et al. Role of micronized progesterone in maintenance therapy following arrested preterm labor: a randomized controlled trial
ATE470669T1 (de) D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere
Simo et al. The impact of sexual activity during the third trimester of pregnancy on labor outcome in nulliparous women
Dávila et al. Dual Protection Contraception Among South African Women
Rageh et al. The Association between Serum Estradiol and Progesterone on the Same Day of FET and the Pregnancy Outcome, a cross-sectional study
Di Carlo et al. LEPTIN AND MENOPAUSE

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees